non-Hodgkin lymphoma

Janssen to develop Darzalex successor with Genmab

https://pharmaphorum.com/news/janssen-to-develop-darzalex-successor-with-genmab/

FDA approves Roche’s $90,000 lymphoma combination

https://pharmaphorum.com/news/fda-approves-roches-90000-lymphoma-combination/

Morphosys to take on CAR-Ts in NHL with promising antibody

https://pharmaphorum.com/news/morphosys-to-take-on-car-ts-in-nhl-with-promising-antibody/

Gilead expands CAR-T deal with MaxCyte, Precision files for $100m IPO

https://pharmaphorum.com/news/gilead-expands-car-t-deal-with-maxcyte-precision-files-for-100m-ipo/

https://pharmaphorum.com/news/takedas-adcetris-cleared-nhs-funding-aggressive-blood-cancer/

Kite and Fosun appoint leader for CAR-T debut in China

https://pharmaphorum.com/news/kite-pushes-t-cell-joint-venture-china/

J&J/AbbVie blood cancer drug gets fifth US indication

https://pharmaphorum.com/news/jjabbvie-blood-cancer-drug-gets-fifth-us-indication/

Juno boosted by CAR-T trial findings in NHL

https://pharmaphorum.com/news/juno-boosted-car-t-trial-findings-nhl/

Close in 10 seconds

Pharmaphorum.com

Search